In a large study of 429,595 adults aged 65 years or older, adjuvanted and high-dose influenza vaccines showed no significant ...

Knowing how many people are vaccinated against an existing or re-emerging threat is a key factor guiding public health decisions, but such information is often sparse or non-existent in many regions, ...

Researchers are working on a solution that could make vaccines easier to store and transport.

Shionogi & Co. looks set to put its COVID-19 vaccine into practical use by the end of March 2022 following a government ...

The recombinant zoster vaccine (Shingrix) is very effective against the viral rash, but research has found that it may also ...

For children — and many adults — the fear of injections remains a major barrier to vaccination. But research led by Elodie Segura, PhD, from the Immunity and Cancer Laboratory at the Institut Curie in ...

A shingles shot may dramatically reduce the risk of heart attacks, strokes, and death in people with heart disease.

Opinion: The Trump administration’s recent censorship of vaccine research sets a dangerous precedent, writes A.J. Russo.